News
Champions Oncology
CSBR · NASDAQ
$4.81+$0.12 (+2.56%)TodayMarket closed ·
Prev close $4.69
Latest news
- News
Champions Oncology Q3 2026 Earnings Call Transcript
- News
Full Transcript: Champions Oncology Q1 2027 Earnings Call
- News
Full Transcript: Champions Oncology Q4 2026 Earnings Call
- News
Champions Oncology Q1 Adj. EPS $0.05 Up From $0.01 YoY, Sales $15.232M Up From $13.995M YoY
- Press releaseACCESS Newswire
Champions Oncology Reports Revenue of $15.2 Million
- News
Champions Oncology Q4 Adj. EPS $0.01 Beats $(0.05) Estimate, Sales $13.835M Beat $12.886M Estimate
- Press releaseACCESS Newswire
Champions Oncology Reports Record Annual Revenue of $59 Million
- News
Champions Oncology Q3 Adj. EPS $0.04 Misses $0.09 Estimate, Sales $16.559M Miss $16.613M Estimate
- Press releaseACCESS Newswire
Champions Oncology Reports Revenue of $16.6 Million
- NewsVishaal Sanjay
4 Biotech Stocks That Are Showing Weakness: Momentum Scores Fading Over The Past Week
- News
Market-Moving News for September 12th
- News
A Preview Of Champions Oncology's Earnings
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.